Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
16.60B | 62.70B | 66.68B | 64.61B | 50.61B | 45.06B | Gross Profit |
2.78B | 10.03B | 10.54B | 11.35B | 8.64B | 8.68B | EBIT |
641.00M | 1.20B | 2.56B | 3.54B | 1.50B | 1.52B | EBITDA |
1.30B | 4.80B | 5.69B | 6.02B | 4.08B | 3.88B | Net Income Common Stockholders |
570.00M | 1.53B | 2.43B | 2.60B | 1.37B | 1.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
252.00M | 241.00M | 214.00M | 411.00M | 198.00M | 177.00M | Total Assets |
50.21B | 50.12B | 46.43B | 46.50B | 39.69B | 36.22B | Total Debt |
11.93B | 10.73B | 7.90B | 10.99B | 7.49B | 4.90B | Net Debt |
11.67B | 10.49B | 7.69B | 10.58B | 7.29B | 4.72B | Total Liabilities |
22.09B | 21.69B | 22.10B | 23.81B | 18.64B | 16.30B | Stockholders Equity |
28.12B | 28.42B | 24.33B | 22.70B | 21.05B | 19.93B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.83B | 3.72B | -3.13B | -2.38B | 2.27B | Operating Cash Flow |
0.00 | 3.69B | 6.77B | -533.00M | 292.00M | 3.85B | Investing Cash Flow |
0.00 | -5.76B | -2.46B | -2.24B | -2.41B | -2.12B | Financing Cash Flow |
0.00 | 2.10B | -4.51B | 2.98B | 2.14B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥16.08B | 10.53 | 3.36% | -5.97% | -37.27% | ||
71 Outperform | ¥14.05B | 15.16 | 1.70% | 4.25% | -18.59% | ||
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
64 Neutral | ¥14.43B | 17.26 | 1.53% | 0.59% | -15.61% | ||
61 Neutral | ¥14.30B | 25.86 | 1.94% | 4.72% | 20.48% | ||
58 Neutral | ¥13.43B | 38.23 | 2.41% | 1.59% | -57.66% | ||
56 Neutral | ¥13.91B | 26.10 | 0.30% | -2.04% | ― |